Task: Answer the multiple-choice question.
Query: Which compound exhibits a 1.499% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) Cc1ccccc1OC/C(O)=C(\C#N)c1nc2ccccc2[nH]1
(b) Cc1nn(-c2ccc(F)cc2)c(Cl)c1/C=C(\CC(=O)O)c1nc2ccccc2s1
(c) COc1ccc(-n2nnc3c(SCC(=O)OCc4ccccc4)ncnc32)cc1
(d) COc1cccc(NC(=O)COc2ccccc2)c1
Answer: c. COc1ccc(-n2nnc3c(SCC(=O)OCc4ccccc4)ncnc32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(-n2nnc3c(SCC(=O)OCc4ccccc4)ncnc32)cc1
COc1ccc(-n2nnc3c(SCC(=O)OCc4ccccc4)ncnc32)cc1
benzyl 2-[3-(4-methoxyphenyl)triazolo[4,5-d]pyrimidin-7-yl]sulfanylacetate